Pellet Procedures Product Revenue was Biote’s largest product and service line in fiscal 2025, bringing in $411.11M of $579.66M (71%).
| Product and Service | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 |
|---|---|---|---|---|---|
| Pellet Procedures Product Revenue | $386.86M | $422.97M | $450.99M | $411.11M | |
| Dietary Supplements | $97.24M | $114.27M | $108.05M | $128.65M | |
| Disposable Trocars Product Revenue | $5.09M | $9.96M | $13.04M | $14.56M | |
| Other Service Revenue | — | $2.09M | $6.81M | $8.57M | |
| Service Revenue | $5.34M | $8.36M | $3.00K | — | |
| Shipping Fees & Other Product Revenue | — | $516.00K | $4.64M | $6.45M | |
| Training Service Revenue | $2.92M | $3.51M | $4.37M | $3.23M | |
| Contract-Term Services Revenue | $2.55M | $2.76M | $3.68M | $4.09M | |
| Product Revenue | $1.17M | $2.21M | $3.06M | $3.00M | |
| Shipping Fees Product Revenue | $213.00K | — | — | — | |
| Total | $501.39M | $566.65M | $594.63M | $579.66M |
Biote brought in $579.66M from its eight product and service lines in fiscal 2025, the year ended December 31, 2025. Biote regrouped these lines after fiscal 2024, so the total does not compare directly with that year's $594.63M. Pellet Procedures Product Revenue was the largest at $411.11M (70.9%), ahead of Dietary Supplements at $128.65M (22.2%) and Disposable Trocars Product Revenue at $14.56M (2.5%). The other five lines brought in $25.34M combined.
Compared with fiscal 2024, Dietary Supplements grew fastest, up 19.1% to $128.65M, while Pellet Procedures Product Revenue fell the most, down 8.8% to $411.11M.
Biote began breaking out Other Service Revenue in fiscal 2023 and Shipping Fees & Other Product Revenue in fiscal 2023. Biote stopped reporting Shipping Fees Product Revenue ($213.00K in fiscal 2022) and Service Revenue ($3.00K in fiscal 2024) as separate lines.
United States was Biote’s largest region in fiscal 2025, bringing in $557.77M of $560.77M (99%).
| Geography | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 |
|---|---|---|---|---|---|
| United States | $488.23M | $545.51M | $573.66M | $557.77M | |
| All Other | $1.17M | $2.21M | $3.06M | $3.00M | |
| Total | $489.40M | $547.72M | $576.72M | $560.77M |
Biote brought in $560.77M from its two regions in fiscal 2025, the year ended December 31, 2025. That was down 2.8% from $576.72M in fiscal 2024. United States was the largest at $557.77M (99.5%), ahead of All Other at $3.00M (0.5%).
From fiscal 2022 to 2025, combined revenue from these regions grew from $489.40M to $560.77M, a compound annual growth rate of 4.6%. United States' share held steady at about 99.5%.
Biote (BTMD) reports its revenue by product and service and by geography. In fiscal 2025, Pellet Procedures Product Revenue was its largest product and service line, bringing in $411.11M (70.9% of the total), followed by Dietary Supplements at $128.65M (22.2%).
Pellet Procedures Product Revenue was Biote's largest product and service line in fiscal 2025, bringing in $411.11M, or 70.9% of the $579.66M total across its eight product and service lines.
United States was Biote's largest region in fiscal 2025, bringing in $557.77M, or 99.5% of the $560.77M total across its two regions.
Every figure comes from Biote's annual financial filings, as reported. Each line keeps the name Biote gives it, and years follow its fiscal calendar.
Biote's revenue by product and service goes back to fiscal 2021, with figures through fiscal 2025. The latest four fiscal years are free to view, and the full history is available with a Business Quant subscription.